Altis Labs is a Toronto-based company building AI endpoints for oncology clinical trials. Its prognostic AI model, IPRO, generates survival predictions from routinely acquired radiology scans and was trained with leading cancer centers on a large multimodal oncology database linking imaging, molecular, clinical, and outcomes data. Top-20 biopharma companies use the platform to analyze phase 1-4 trial data, and its AI endpoint delivered Phase 3 validation in Johnson & Johnson's post-hoc analysis of the MARIPOSA lung cancer trial.
1
Round
1
Industry
4
Tags
Sep 17, 2026
Latest raise
Funding activity · 1 round
Sep 17, 2026
$25M
Series A
Led by OrbiMed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
